Trial Profile
A Study to Evaluate the Predictors of Good Response to Tolvaptan in Patients With Refractory Ascites associated with Cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Adverse reactions; Therapeutic Use
- 08 Mar 2016 New trial record